Related Experiment Video
Updated: Oct 21, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
[Topical BCG therapy of in situ cancer of the urinary bladder]
Abstract:
Ten patients with primary, secondary and concurrent Tis were treated by intravesically instilled BCG-solution. A complete tumor remission could be obtained in 6 patients. Local toxicity was the reason for discontinuing the treatment in 2 patients. One patient developed a granulomatous prostatitis during the treatment. Although significant side effects did occur we think that topical BCG therapy is an effective treatment modality in Tis of the urinary bladder.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urologic Endoscopic Procedure: Cystoscopic Examination